Salinomycin inhibits prostate cancer growth and migration via induction of oxidative stress

This publication has 64 references indexed in Scilit:

• Activation of NF-κB by TMPRSS2/ERG Fusion Isoforms through Toll-Like Receptor-4
  Cancer Research, 2011
• Arachidonic Acid Pathway Members PLA2G7, HPGD, EPHX2, and CYP4F8 Identified as Putative Novel Therapeutic Targets in Prostate Cancer
  The American Journal of Pathology, 2011
• Regulation of cancer cell metabolism
  Nature Reviews Cancer, 2011
• Tumour-initiating stem-like cells in human prostate cancer exhibit increased NF-κB signalling
  Nature Communications, 2011
• Therapeutics formulated to target cancer stem cells: Is it in our future?
  Cancer Cell International, 2011
• Salinomycin sensitizes cancer cells to the effects of doxorubicin and etoposide treatment by increasing DNA damage and reducing p21 protein
  British Journal of Pharmacology, 2010
• ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients' outcome
  Laboratory Investigation, 2009
• High Aldehyde Dehydrogenase Activity: A Novel Functional Marker of Murine Prostate Stem/Progenitor Cells
  The International Journal of Cell Cloning, 2009
• Invasive prostate cancer cells are tumor initiating cells that have a stem cell-like genomic signature
  Clinical & Experimental Metastasis, 2009
• Oxidative stress in prostate cancer
  Published by Elsevier ,2009